Stool Transplants to Treat Refractory Clostridium Difficile Colitis

Abroad (travel likely)RecruitingPHASE2

Conditions

Clostridium Difficile Colitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (Gary M Cox, MD) · gary.cox@duke.edu · 919-668-3271
Contact: Principal Investigator (Gary M Cox, MD)

Study leads

Gary M Cox, MD
Principal Investigator
Duke University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Clostridium Difficile · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rome, Italy

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Ulcerative Colitis · Inflammatory Bowel Diseases · Clostridioides Difficile Infection

Abroad (travel likely)RecruitingPHASE1

Calgary, Canada · Edmonton, Canada

Safety and Efficacy of Fecal Microbiota Transplantation

Crohn Disease · Ulcerative Colitis · Celiac Disease

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong